{"title":"다음 뉴스 ─ 전체기사 ─ IT","url":"https://news.daum.net/breakingnews/digital","favicon":"https://news.daum.net/breakingnews/favicon.ico","elements":[{"title":"레벨 인피니트, ‘백야극광’ ‘영웅이여, 봄이 왔노라’ 이벤트 진행","contents":"매경게임진<span class=\"txt_bar\"> · </span><span class=\"info_time\">12:12</span>","link":"https://v.daum.net/v/20240905121204938","retrieved":1725506439049},{"title":"[콘텐츠 핫&뉴] ‘배틀그라운드’ 태이고 맵 일부 지역 업데이트","contents":"매경게임진<span class=\"txt_bar\"> · </span><span class=\"info_time\">12:12</span>","link":"https://v.daum.net/v/20240905121200931","retrieved":1725506439049},{"title":"[부음] 임종성(CCGI 아시아 전무이사)씨 모친상","contents":"전자신문<span class=\"txt_bar\"> · </span><span class=\"info_time\">12:04</span>","link":"https://v.daum.net/v/20240905120450771","retrieved":1725506439049},{"title":"개인정보위, 내년 예산안 646억…AI 개인정보 기술 개발에 87억 편성","contents":"이데일리<span class=\"txt_bar\"> · </span><span class=\"info_time\">12:02</span>","link":"https://v.daum.net/v/20240905120257673","retrieved":1725506439051},{"title":"개인정보위, 내년 예산안 646억원…R&D 예산 전년比 22%↑","contents":"헤럴드경제<span class=\"txt_bar\"> · </span><span class=\"info_time\">12:02</span>","link":"https://v.daum.net/v/20240905120231637","retrieved":1725506439052},{"title":"\"제약·바이오 산업 경쟁력 강화\"…정부, 글로벌 신약 개발 박차","contents":"뉴스1<span class=\"txt_bar\"> · </span><span class=\"info_time\">12:02</span>","link":"https://v.daum.net/v/20240905120225630","retrieved":1725506439052},{"title":"국산 항암제 '렉라자' 美통과…정부, 글로벌 신약 개발 속도낸다","contents":"이데일리<span class=\"txt_bar\"> · </span><span class=\"info_time\">12:01</span>","link":"https://v.daum.net/v/20240905120154596","retrieved":1725506439053},{"title":"[지금은 기후위기] 올해 여름은 무더웠다","contents":"아이뉴스24<span class=\"txt_bar\"> · </span><span class=\"info_time\">12:01</span>","link":"https://v.daum.net/v/20240905120151588","retrieved":1725506439055},{"title":"개인정보위 내년 예산안 646억원···올해 比 1.2%↓","contents":"서울경제<span class=\"txt_bar\"> · </span><span class=\"info_time\">12:01</span>","link":"https://v.daum.net/v/20240905120128541","retrieved":1725506439057},{"title":"MZ세대 겨냥한 ‘개이득’ 카드…우본, 체크카드로 다양한 혜택 제공","contents":"데일리안<span class=\"txt_bar\"> · </span><span class=\"info_time\">12:01</span>","link":"https://v.daum.net/v/20240905120125535","retrieved":1725506439058},{"title":"5% 캐시백·OTT 할인…우체국 체크카드 혜택 눈길","contents":"뉴시스<span class=\"txt_bar\"> · </span><span class=\"info_time\">12:01</span>","link":"https://v.daum.net/v/20240905120116524","retrieved":1725506439060},{"title":"개인정보위, 2025년도 예산안 646억원 편성","contents":"디지털타임스<span class=\"txt_bar\"> · </span><span class=\"info_time\">12:01</span>","link":"https://v.daum.net/v/20240905120113517","retrieved":1725506439061},{"title":"개인정보위 내년 예산 646억…개인정보보호 R&D 예산 22% 증가","contents":"뉴시스<span class=\"txt_bar\"> · </span><span class=\"info_time\">12:01</span>","link":"https://v.daum.net/v/20240905120103504","retrieved":1725506439062},{"title":"국산 항암제 '렉라자' 美 FDA 승인 성공 뒤엔 '정부 R&D 지원'","contents":"뉴시스<span class=\"txt_bar\"> · </span><span class=\"info_time\">12:01</span>","link":"https://v.daum.net/v/20240905120102503","retrieved":1725506439063},{"title":"개인정보위, 2025년도 예산 646억 편성…R&D 예산 22% ↑","contents":"아시아경제<span class=\"txt_bar\"> · </span><span class=\"info_time\">12:00</span>","link":"https://v.daum.net/v/20240905120040474","retrieved":1725506439065}]}